Test Catalog

Test

Code
E068
Name
ADALIMUMAB AND ANTIBODIES TO ADALIMUMAB QUANTITATION
Description

Alternative Names: E068, ADA/ AB TO ADA QUANT, Abrilada, Amjevita, Cyltezo, Hadlima, Hulio, Hymiroz, Idacio, Yusimry, ADALIMUMAB / AB TO ADALIMUMAB, HUMIRA
Includes: Adalimumab, Antibodies to Adalimumab Quantitation
Sample Type: Serum
Preferred Container: Serum Separator Tube (SST)
Sample Volume: 1.0 mL
Minimum Volume: 0.1 mL
Handling Instructions: Collect specimens before next scheduled dose of adalimumab or adalimumab biosimilar (trough specimen). Avoid exposure to biotin (vitamin B7) for 12 hours prior to specimen collection. Separate serum from cells ASAP. Transfer 1 mL serum to a standard transport tube. (Min 0.1 mL)
Transport Temperature: Refrigerated
Specimen Stability: After separation from cells: Ambient: 48 Hours; Refrigerated: 2 Weeks; Frozen: 1 Month
Testing Frequency: Sunday, Monday, Tuesday, Wednesday, Thursday, Friday, Saturday
Expected Turn Around Time: 4 – 8 Days
Testing Facility: ARUP
CPT Codes: 80145; 82397
Note: Adalimumab Quantitation: Results of 0.4 ug/mL or higher indicate the detection of adalimumab or an adalimumab biosimilar. Therapeutic level may vary depending on the disease being treated.
Antibodies to Adalimumab Quantitation: Results of 20 ng/mL or higher indicate the detection of antibodies against adalimumab or an adalimumab biosimilar. Interpret in the context of adalimumab or adalimumab biosimilar trough concentration to determine clinical significance and impact on treatment efficacy.